- Company List - E
- SBOT
Insider Trading activities at Edesa Biotech, Inc. (SBOT)
Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Edesa Biotech, Inc. (SBOT)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Edesa Biotech, Inc..
Table 2 shows the detailed insider transactions.
This company's CIK number is 1540159.
Total stock buying since 2015: $753,861.
Total stock sales since 2015: $903,351.
Total stock option exercises since 2015: $11,440.
Table 1. Yearly summary of insider stock purchases, sales, and option exercises
at Edesa Biotech, Inc. (SBOT).
|
Insider Buying |
Insider Sales |
Option Exercises |
| Year |
Shares | Value |
Shares | Value |
Shares | Value |
| 2024 | 5,000 | $20,000 | 0 | $0 | 0 | $0 |
| 2023 | 0 | $0 | 297,474 | $787,762 | 0 | $0 |
| 2022 | 60,500 | $135,319 | 0 | $0 | 0 | $0 |
| 2021 | 11,500 | $59,715 | 7,992 | $57,942 | 0 | $0 |
| 2020 | 165,912 | $538,827 | 0 | $0 | 0 | $0 |
| 2019 | 0 | $0 | 5,809 | $15,345 | 0 | $0 |
| 2018 | 0 | $0 | 46,713 | $42,302 | 0 | $0 |
| 2015 | 0 | $0 | 0 | $0 | 4,000 | $11,440 |
Table 2. Monthly summary of insider trading at Edesa Biotech, Inc. (SBOT).
| Trading Period |
Insider Buying |
Insider Sales |
Option Exercises |
| year-month |
Shares | Value |
Shares | Value |
Shares | Value |
| 2024-03 | 5,000 | $20,000 | 0 | $0 | 0 | $0 |
| 2023-01 | 0 | $0 | 297,474 | $787,762 | 0 | $0 |
| 2022-06 | 26,000 | $41,380 | 0 | $0 | 0 | $0 |
| 2022-05 | 10,500 | $19,290 | 0 | $0 | 0 | $0 |
| 2022-03 | 24,000 | $74,649 | 0 | $0 | 0 | $0 |
| 2021-03 | 11,500 | $59,715 | 0 | $0 | 0 | $0 |
| 2021-02 | 0 | $0 | 7,992 | $57,942 | 0 | $0 |
| 2020-05 | 5,500 | $16,440 | 0 | $0 | 0 | $0 |
| 2020-03 | 7,000 | $19,835 | 0 | $0 | 0 | $0 |
| 2020-01 | 153,412 | $502,552 | 0 | $0 | 0 | $0 |
| 2019-09 | 0 | $0 | 1,809 | $10,345 | 0 | $0 |
| 2019-03 | 0 | $0 | 4,000 | $5,000 | 0 | $0 |
| 2018-10 | 0 | $0 | 10,047 | $13,189 | 0 | $0 |
| 2018-03 | 0 | $0 | 14,866 | $11,938 | 0 | $0 |
| 2018-02 | 0 | $0 | 21,800 | $17,175 | 0 | $0 |
| 2015-12 | 0 | $0 | 0 | $0 | 4,000 | $11,440 |
Table 3. Detailed insider trading at Edesa Biotech, Inc. (SBOT)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2024-03-25 | Pardeep Nijhawan Medicine Professional Corp | Buy | 5,000 | 4.00 | 20,000 |
| 2023-01-10 | Lumira Capital Investment Management Inc. | Sale | 152,345 | 2.63 | 401,429 |
| 2023-01-09 | Lumira Capital Investment Management Inc. | Sale | 145,129 | 2.66 | 386,333 |
| 2022-06-30 | Pardeep Nijhawan Medicine Professional Corp (Chief Executive Officer) | Buy | 20,000 | 1.60 | 32,080 |
| 2022-06-29 | Brooks Michael J (President) | Buy | 3,000 | 1.49 | 4,482 |
| 2022-06-16 | Brooks Michael J (President) | Buy | 3,000 | 1.61 | 4,818 |
| 2022-05-27 | Pardeep Nijhawan Medicine Professional Corp (Chief Executive Officer) | Buy | 5,000 | 1.92 | 9,600 |
| 2022-05-25 | Brooks Michael J (President) | Buy | 3,500 | 1.74 | 6,090 |
| 2022-05-24 | Pardeep Nijhawan Medicine Professional Corp (Chief Executive Officer) | Buy | 2,000 | 1.80 | 3,600 |
| 2022-03-31 | Pardeep Nijhawan Medicine Professional Corp (Chief Executive Officer) | Buy | 2,000 | 2.99 | 5,972 |
| 2022-03-30 | Pardeep Nijhawan Medicine Professional Corp (Chief Executive Officer) | Buy | 2,000 | 3.05 | 6,098 |
| 2022-03-29 | Pardeep Nijhawan Medicine Professional Corp (Chief Executive Officer) | Buy | 2,000 | 3.02 | 6,034 |
| 2022-03-18 | Pardeep Nijhawan Medicine Professional Corp (Chief Executive Officer) | Buy | 2,000 | 3.85 | 7,700 |
| 2022-03-17 | Pardeep Nijhawan Medicine Professional Corp (Chief Executive Officer) | Buy | 2,000 | 3.26 | 6,514 |
| 2022-03-15 | Pardeep Nijhawan Medicine Professional Corp (Chief Executive Officer) | Buy | 2,000 | 2.80 | 5,598 |
| 2022-03-14 | Brooks Michael J (President) | Buy | 1,250 | 2.79 | 3,486 |
| 2022-03-11 | Pardeep Nijhawan Medicine Professional Corp (Chief Executive Officer) | Buy | 7,000 | 3.12 | 21,833 |
| 2022-03-10 | Brooks Michael J (President) | Buy | 1,000 | 3.22 | 3,223 |
| 2022-03-09 | Pardeep Nijhawan Medicine Professional Corp (Chief Executive Officer) | Buy | 1,500 | 3.05 | 4,569 |
| 2022-03-08 | Brooks Michael J (President) | Buy | 1,250 | 2.90 | 3,622 |
| 2021-03-25 | Pardeep Nijhawan Medicine Professional Corp (Chief Executive Officer) | Buy | 3,000 | 5.25 | 15,750 |
| 2021-03-25 | Brooks Michael J (President) | Buy | 3,500 | 5.19 | 18,165 |
| 2021-03-24 | Pardeep Nijhawan Medicine Professional Corp (Chief Executive Officer) | Buy | 5,000 | 5.16 | 25,800 |
| 2021-02-18 | Oakes Frank R. | Sale | 7,992 | 7.25 | 57,942 |
| 2020-05-27 | Brooks Michael J (President) | Buy | 2,500 | 3.00 | 7,500 |
| 2020-05-26 | Pardeep Nijhawan Medicine Professional Corp (Chief Executive Officer) | Buy | 3,000 | 2.98 | 8,940 |
| 2020-03-29 | Pardeep Nijhawan Medicine Professional Corp (Chief Executive Officer) | Buy | 2,000 | 5.23 | 10,460 |
| 2020-03-17 | Pardeep Nijhawan Medicine Professional Corp | Buy | 5,000 | 1.88 | 9,375 |
| 2020-01-08 | Brooks Michael J (President) | Buy | 1,827 | 4.11 | 7,508 |
| 2020-01-08 | Sistilli Carlo | Buy | 2,436 | 4.11 | 10,011 |
| 2020-01-08 | Lumira Capital Investment Management Inc. | Buy | 140,625 | 3.20 | 450,000 |
| 2020-01-08 | Johnson Lorin K | Buy | 8,524 | 4.11 | 35,033 |
| 2019-09-11 | Oakes Frank R. | Sale | 1,809 | 5.72 | 10,345 |
| 2019-03-06 | Oakes Frank R. (President & CEO) | Sale | 4,000 | 1.25 | 5,000 |
| 2018-10-12 | Morse Daniel E. | Sale | 7,047 | 1.31 | 9,259 |
| 2018-10-12 | Oakes Frank R. (President & CEO) | Sale | 3,000 | 1.31 | 3,930 |
| 2018-03-29 | Morse Daniel E. | Sale | 4,366 | .81 | 3,514 |
| 2018-03-12 | Morse Daniel E. | Sale | 3,500 | .80 | 2,789 |
| 2018-03-09 | Morse Daniel E. | Sale | 7,000 | .81 | 5,635 |
| 2018-02-28 | Morse Daniel E. | Sale | 7,000 | .79 | 5,530 |
| 2018-02-26 | Morse Daniel E. | Sale | 7,000 | .79 | 5,530 |
| 2018-02-22 | Morse Daniel E. | Sale | 7,800 | .78 | 6,115 |
| 2015-12-22 | Oakes Frank R. (President, CEO & Director) | Option Ex | 4,000 | 2.86 | 11,440 |
Insider trading activities including stock purchases, stock sales, and option exercises
of SBOT listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Edesa Biotech, Inc. (symbol SBOT,
CIK number 1540159) see
the Securities and Exchange Commission (SEC) website.